Literature DB >> 11345967

Dimensions of emotionality in a rat model of innate anxiety.

F Ohl1, N Toschi, A Wigger, M S Henniger, R Landgraf.   

Abstract

Emotionality is thought to be multidimensional, with "anxiety" representing one dimension. Dissecting emotional dimensions in animal models is an essential prerequisite for investigating the neurobiological mechanisms that underlie anxiety. The authors used factor analysis to investigate emotional dimensions in normal rats and rats bred for either high or low anxiety-related behavior. Hyperanxious rats were reduced in emotional dimensions in the elevated plus-maze by selection pressure, and a modified hole board test revealed a dissection of their emotionality with precisely defined dimensions. This enabled clear differentiation of "anxiety" from other emotional dimensions including risk assessment behavior and exploration. Factors extracted by analyzing data from a multiple-test battery corresponded to particular test characteristics rather than to emotional dimensions. The approach used might help to develop specific treatment strategies for anxiety disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11345967

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  21 in total

1.  Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Authors:  Yonghui Li; Sa Li; Chuguang Wei; Huiying Wang; Nan Sui; Gilbert J Kirouac
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

2.  The delayed effects of chronic unpredictable stress on anxiety measures.

Authors:  Leslie Matuszewich; Jared J Karney; Samantha R Carter; Steven P Janasik; Johanna L O'Brien; Ross D Friedman
Journal:  Physiol Behav       Date:  2006-12-28

3.  Functional perturbation of forebrain principal neurons reveals differential effects in novel and well-learned tasks.

Authors:  Emily T Stoneham; Daniel G McHail; Katelyn N Boggs; Sarah H Albani; Jason A Carty; Rebekah C Evans; Kelly A Hamilton; Victoria M Saadat; Samanza Hussain; Maggie E Greer; Theodore C Dumas
Journal:  Brain Res       Date:  2017-06-27       Impact factor: 3.252

Review 4.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

5.  Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).

Authors:  Anke Post; Frauke Ohl; Osborne F X Almeida; Elisabeth B Binder; Monika Rücker; Sandra Welt; Elke Binder; Florian Holsboer; Inge Sillaber
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

6.  Novelty-seeking behavior predicts vulnerability in a rodent model of depression.

Authors:  Kristen A Stedenfeld; Sarah M Clinton; Ilan A Kerman; Huda Akil; Stanley J Watson; Alan F Sved
Journal:  Physiol Behav       Date:  2011-02-12

7.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

8.  Aggression and anxiety: social context and neurobiological links.

Authors:  Inga D Neumann; Alexa H Veenema; Daniela I Beiderbeck
Journal:  Front Behav Neurosci       Date:  2010-03-30       Impact factor: 3.558

9.  Variation in vasopressin receptor (Avpr1a) expression creates diversity in behaviors related to monogamy in prairie voles.

Authors:  Catherine E Barrett; Alaine C Keebaugh; Todd H Ahern; Caroline E Bass; Ernest F Terwilliger; Larry J Young
Journal:  Horm Behav       Date:  2013-01-28       Impact factor: 3.587

10.  Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.

Authors:  Zhongqi Zhang; Gery Schulteis
Journal:  Pharmacol Biochem Behav       Date:  2008-01-29       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.